BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 7303757)

  • 1. [Immunosuppressive treatment of chronic liver diseases in the clinical biochemical, immunological and histological evaluation of the liver].
    Boroń P; Szpakowicz T; Bobrowska E; Boroń-Kaczmarska A; Prokopowicz D; Borzuchowska A
    Z Gesamte Inn Med; 1981 May; 36(10):318-21. PubMed ID: 7303757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoglobulins and histological findings in chronic liver diseases treated with immunosuppressive agents].
    Bauch K; Büttner W; Lewicki I; Zimmermann S; Dempe A
    Z Gesamte Inn Med; 1973 Jun; 28(11):Suppl:169-72. PubMed ID: 4728086
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive therapy in chronic liver disease.
    Sherlock S
    Minerva Med; 1978 Aug; 69(38):2605-9. PubMed ID: 714260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indications, method and effectiveness of immunosuppressive treatment in chronic active hepatopathies. 3. Evolution of the immunologic picture. IV. Improvement of the functional parameters].
    Nicolescu T; Bittman E; Stoiculescu P; Bordeianu A; Boroş I; Jinga V; Moucha R; Ciontescu L
    Med Interna (Bucur); 1974 Apr; 26(4):465-78. PubMed ID: 4839353
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of immunoglobulins in the immunosuppressive therapy of liver diseases].
    Bauch K; Zimmermann S; Lewicki I; Büttner W
    Dtsch Gesundheitsw; 1972 Nov; 27(45):2135-7. PubMed ID: 4650683
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunological implications in hepatic physiopathology].
    Nicolaescu T
    Rev Roum Physiol; 1971; 8(4):313-22. PubMed ID: 5128516
    [No Abstract]   [Full Text] [Related]  

  • 7. [Indications, method and effectiveness of immunosuppressive treatment in chronic active hepatopathies. I. Changes in the general dynamics of the disease. II. Slowing-down of the chronicization process].
    Nicolaescu T; Stoiculescu P; Bittman E; Bordeianu A; Gheorghe N; Pintilescu V; Metz L
    Med Interna (Bucur); 1974 Apr; 26(4):453-64. PubMed ID: 4839352
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunosuppressive drugs in the treatment of liver diseases (author's transl)].
    Magnenat P
    Ther Umsch; 1979 May; 36(5):432-8. PubMed ID: 451956
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunosuppressive therapy in active chronic hepatopathies].
    Buligescu L; Ciontea M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(3):241-56. PubMed ID: 30138
    [No Abstract]   [Full Text] [Related]  

  • 10. Results of immunosuppressive treatment: Prognosis in chronic active hepatitis.
    Pelikán V; Seidlová V; Sánová J; Komenda S
    Acta Hepatogastroenterol (Stuttg); 1975 Aug; 22(4):210-4. PubMed ID: 1179942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of chronic hepatitis. A comparative study of the effect azathioprine and (+)-cyanidanol-3].
    Aguilar Reina J; de la Santa López J; Cuadras Avellana CM; Kern A
    Fortschr Med; 1978 Jan; 96(2):75-9. PubMed ID: 74352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cellular immunity in chronic liver diseases during immunosuppressive treatment.
    Salerno F; Tornaghi G; Cappellini MD; Fargion S; Fiorelli G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:272. PubMed ID: 4851922
    [No Abstract]   [Full Text] [Related]  

  • 13. [The histological picture of chronic-aggressive hepatitis in immunosuppressive therapy].
    Förster E; Maas D; Beck K; Oehlert W; Birnbaum F
    Dtsch Med Wochenschr; 1971 Jan; 96(1):1-5. PubMed ID: 5312887
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome.
    Schiano TD; Te HS; Thomas RM; Hussain H; Bond K; Black M
    Am J Gastroenterol; 2001 Oct; 96(10):2984-91. PubMed ID: 11693337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoimmune hepatitis: clinical forms and related factors to their response to treatment].
    Dávalos M; Román R; Bustios C; Zumaeta E; Yabar A
    Rev Gastroenterol Peru; 2004; 24(4):305-13. PubMed ID: 15614298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of customary treatment in chronic active liver disease: causes and management.
    Schalm SW; Ammon HV; Summerskill WH
    Ann Clin Res; 1976 Jun; 8(3):221-7. PubMed ID: 793499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoimmune chronic hepatitis in children].
    Nałecz A; Janowicz W; Pawłowska J; Socha J
    Wiad Lek; 1989 Jul 1-15; 42(13-15):862-6. PubMed ID: 2634314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term therapy of liver diseases].
    Renger F; Dökert B
    Z Gesamte Inn Med; 1973 Jun; 28(11):Suppl:165-8. PubMed ID: 4728085
    [No Abstract]   [Full Text] [Related]  

  • 19. [For which liver diseases is immunosuppressive therapy indicated?].
    Bannaski H
    Med Klin Prax; 1982 Aug; 77(16-17):66-71, 74. PubMed ID: 7132889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunodepressants in chronic liver diseases (a review of the literature and the authors' own data)].
    Podymova SD; Nasonov EL
    Ter Arkh; 1976; 48(3):40-8. PubMed ID: 795076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.